tailieunhanh - Optimisation of an immunohistochemistry method for the determination of androgen receptor expression levels in circulating tumour cells

AZD3514 inhibits and down regulates the androgen receptor (AR) and has undergone clinical trials in prostate cancer. To provide proof-of-mechanism (POM) in patients, an immunohistochemistry (IHC) method for determination of AR in circulating tumour cells (CTC) was developed and validated. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN